Importantly, the fold changes in insulin and leptin levels in our mouse model are in the same range as those in DIO mouse models of EI of metabolic phenotypes (Fullston et al. 2013; Wei et al. 2014), showing the validity of our approach to alter those hormone levels in the absence of obesity. The gene discussed is INS; the disease is Obesity.